#Blog

Access
All Articles




Radio Compass Blog

FDA highlights data-integrity concerns at Pfizer’s India unit; FDA requests removal of all ranitidine products

This week, N-nitrosodimethylamine (NDMA) is back in news as the FDA requests manufacturers to withdraw ranitidine from the market immediately due to the presence of the cancer-causing impurity. Bristol Myers bagged FDA approval for its multiple scl...
2020-04-02

https://www.pharmacompass.com/radio-compass-blog/fda-highlights-data-integrity-concerns-at-pfizer-s-india-unit-fda-requests-removal-of-all-ranitidine-products

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 1087
Share Share info

#Blog

Access
All Articles




Radio Compass Blog

Chinese industrial activity revival at 98.6 percent, officials assure of API supplies

While the world feels the heat of the Covid-19 pandemic with the global pharmaceutical supply chain getting impacted, normalcy is returning to China. According to new reports, the production of drugs and APIs in China is also returning to normal. I...
2020-04-02

https://www.pharmacompass.com/radio-compass-blog/chinese-industrial-activity-revival-at-98-6-percent-officials-assure-of-api-supplies

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 540
Share Share info

#Blog

Access
All Articles




Radio Compass Blog

Covid-19 treatments stumble; India restricts Trump-backed drug (HCQ) exports as FDA lifts ban on Ipca to get supplies

This week, Phispers has some bad news on the potential treatments for Covid-19. First, studies have shown limited clinical improvement due to treatments like hydroxychloroquine, lopinavir and ritonavir. Second, Gilead stopped offering its experim...
2020-03-26

https://www.pharmacompass.com/radio-compass-blog/covid-19-treatments-stumble-india-restricts-trump-backed-drug-hcq-exports-as-fda-lifts-ban-on-ipca-to-get-supplies

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 1579
Share Share info

#Blog

Access
All Articles




Radio Compass Blog

Hydroxychloroquine: Hype versus reality

The President of United States Donald Trump’s tweet late last week has swung the pharmaceutical industry’s focus on hydroxychloroquine, an anti-malarial drug which has been in use since the 1950s and is now used to treat a variety of...
2020-03-23

https://www.pharmacompass.com/radio-compass-blog/hydroxychloroquine-hype-versus-reality

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 5155
Share Share info

#Blog

Access
All Articles




Radio Compass Blog

Pipeline Prospector Feb 2020: Coronavirus Developments & Deal Updates

In February, PharmaCompass and SCORR Marketing had announced the launch of the Pipeline Prospector, a free-access database of global drug development deals and updates designed for executives in the drug development industry. While our re...
2020-03-19

https://www.pharmacompass.com/radio-compass-blog/pipeline-prospector-feb-2020-coronavirus-developments-deal-updates

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 2343
Share Share info

#Blog

Access
All Articles




Radio Compass Blog

US plans to reduce drug manufacturing dependence on China, India; Cross-contamination problems at Cipla

This week, Phispers has more updates on Covid-19. The US is preparing an executive order that will reduce the country’s drug dependence on China and India. German biotech CureVac was in news for not just its experimental coronavirus vaccine...
2020-03-19

https://www.pharmacompass.com/radio-compass-blog/us-plans-to-reduce-drug-manufacturing-dependence-on-china-india-cross-contamination-problems-at-cipla

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 1031
Share Share info

#Blog

Access
All Articles




Radio Compass Blog

Covid-19 update: Indian firms airlift APIs from China; FDA suspends foreign inspections; pharma events get cancelled

This week, Phispers brings you more updates on the novel coronavirus, as the WHO declared its spread a pandemic. The USFDA has postponed most inspections outside of the US through April. It has also issued Form 483s to three Indian drugmakers &md...
2020-03-12

https://www.pharmacompass.com/radio-compass-blog/covid-19-update-indian-firms-airlift-apis-from-china-fda-suspends-foreign-inspections-pharma-events-get-cancelled

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 2805
Share Share info

#Blog

Access
All Articles




Radio Compass Blog

EMA raises clinical data-integrity concerns at Indian CRO; Sandoz to pay record US$ 195 million fine

This week, Phispers has more updates on Covid-19. While US lawmakers approved an emergency bill of US$ 8.3 billion to fund the government’s response to the coronavirus outbreak, China had allocated US$ 15.58 billion in special funds by March ...
2020-03-05

https://www.pharmacompass.com/radio-compass-blog/ema-raises-clinical-data-integrity-concerns-at-indian-cro-sandoz-to-pay-record-us-195-million-fine

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 1128
Share Share info

#Blog

Access
All Articles




Radio Compass Blog

COVID-19: India restricts drug exports amid rising prices of essential bulk drugs; FDA announces first drug shortage

Now that it has been established that the novel coronavirus is going to globally impact the drug supply chain, it becomes imperative to analyze the extent of the impact. Since the outbreak of the novel coronavirus — COVID-19 — in ...
2020-03-04

https://www.pharmacompass.com/radio-compass-blog/covid-19-india-restricts-drug-exports-amid-rising-prices-of-essential-bulk-drugs-fda-announces-first-drug-shortage

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 5542
Share Share info

#Blog

Access
All Articles




Radio Compass Blog

World takes stock of Covid-19 impact on drug supply chain; Sanofi to create major European API firm

This week too, Phispers brings you an update on the novel coronavirus. While China is trying to curtail the impact of Covid-19 on its economy, the developed world is looking at how to protect its drug supply chain from such adversities. Sanofi is...
2020-02-27

https://www.pharmacompass.com/radio-compass-blog/world-takes-stock-of-covid-19-impact-on-drug-supply-chain-sanofi-to-create-major-european-api-firm

#Phispers by PHARMACOMPASS PharmaCompass on Linkedin
Views: 2745
Share Share info

Radio Compass Blog for All Pharma Articles Blog: All Pharma Articles Post an enquiry PharmaCompass.com

#Phispers - PharmaCompass' Weekly News Recap of key industry developments so that users can quickly update themselves to be in the know.

#PharmaFlow - PharmaCompass' Data Compilation of Major Pharma & Biotech Deals. We offer Free Excel Compilations for users to perform their own analysis.

#SpeakPharma - PharmaCompass' Q&A where we follow fast-growing, innovative companies and profile them to make our users aware about new innovative capabilities and developments.

#RadioData - PharmaCompass' Data Compilations of Product & Company Sales, Non Compliances, New Drug Launches, FDA Facility Registrations, Medicare Sales Data etc. We offer Free Excel Compilations for users to perform their own analysis.

Access Interactive Dashboards
Access
Interactive
Dashboards
Access All Data
Access
All Data

Most Read Articles Most Read

  1. cGMP Non-Compliance Recap 2019
  2. DMF submissions in 2019: India maintains bulk drug supply supremacy to US
  3. Novartis leads in new drug approvals; Vertex’s cystic fibrosis med holds highest sales potential
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty